Dana-Farber Cancer Institute · 1 day ago
Postdoctoral Research Fellow - Lane Lab
Dana-Farber Cancer Institute is a leader in life changing breakthroughs in cancer research and patient care. They are seeking highly motivated postdoctoral fellows who are passionate about uncovering fundamental mechanisms of cancer biology and translating these discoveries into new therapeutic strategies.
CommunitiesHealth CareHealth DiagnosticsHospitalNon ProfitOncology
Responsibilities
Individual projects will be tailored to the candidate’s background and interests, with additional opportunities for collaborative work with the Cancer Program at the Broad Institute of Harvard and MIT
Current Areas Of Focus In The Lab Include
Leukemia biology (pathogenesis, hematopoiesis, and stem cell biology)
Dendritic cell development, function, and malignant transformation
Mechanisms of resistance to cancer therapies
Cancer genetics, including sex-based differences in malignancy
Qualification
Required
Candidates should hold a PhD, MD, or MD/PhD
Demonstrate a strong track record of productivity
Excellent written and verbal communication skills
Preferred
Experience with bioinformatics and programming for analysis of sequencing-based datasets (DNA, RNA, epigenetic)
Preferred experimental skills include tissue culture, flow cytometry, and standard molecular and cell biology techniques
Experience with mouse models is advantageous but not required
Company
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute is a center dedicated to carrying out adult and pediatric cancer treatment activities and advanced research.
H1B Sponsorship
Dana-Farber Cancer Institute has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (191)
2024 (145)
2023 (155)
2022 (139)
2021 (105)
2020 (113)
Funding
Current Stage
Late StageTotal Funding
$88.08MKey Investors
Elaine and Eduardo Saverin FoundationThe DeGregorio Family FoundationLlama
2025-11-24Grant· $20M
2025-05-06Grant· $1M
2024-09-24Grant· $0.5M
Recent News
Medical Xpress - latest medical and health news stories
2025-12-29
MarketScreener
2025-12-16
Company data provided by crunchbase